Journal
BJU InternationalMore Press Releases related to this journalEdited By: Prokar Dasgupta
Print ISSN: 1464-4096 Online ISSN: 1464-410X
Impact Factor: 4.688
More Press Releases in: |
Media ToolkitContact Publicity to:
|
May 06, 2016
Testosterone Undecanoate Improves Sexual Function in Men with Type 2 Diabetes and Very Low Testosterone
In a recent placebo-controlled study, long acting testosterone undecanoate (an ester of testosterone) improved erectile function, intercourse satisfaction, and sexual desire scores in type 2 diabetic men with severe hypogonadism, a condition in which the body doesn't produce enough testosterone. Only sexual desire improved significantly with testosterone replacement therapy in those with mild hypogonadism.
“The study’s results also suggest that trials of testosterone therapy should be for a minimum of 6 months and not shorter periods as suggested by some guidelines,” said Dr. Geoffrey Hackett, lead author of the BJU International study.